Radiographic and Pain Outcomes from a Phase 3 Extension Study Evaluating the Safety and Efficacy of Lorecivivint in Subjects with Severe Osteoarthritis of the Knee (OA-07): 36 Month Single Blind and Placebo Crossover Phase Results

被引：0
|
作者：
Yazici, Yusuf [1 ]
Swearingen, Christopher [2 ]
Lopez, Victor [3 ]
Britt, Jon [4 ]
Kennedy, Sarah [5 ]
Tambiah, Jeyanesh [2 ]
McAlindon, Timothy [6 ]
机构：
[1] NYU Grossman Sch Med, La Jolla, CA USA
[2] Biosplice Therapeut Inc, San Diego, CA USA
[3] Biosplice Therapeut Inc, Santa Clarita, CA USA
[4] Biosplice Therapeut Inc, Los Angeles, CA USA
[5] Biosplice Therapeut Inc, Superior, CO USA
[6] Tufts Med Ctr, Arlington, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0820
引用
收藏
页码：1642 / 1644
页数：3
相关论文
共 50 条
  • [41] Dupilumab in Patients with Corticosteroid-Dependent Severe Asthma: Efficacy and Safety Results from the Randomized, Double-Blind, Placebo-Controlled Phase 3 LIBERTY ASTHMA VENTURE Study
    Rabe, K. F.
    Nair, P. K.
    Brusselle, G. G.
    Maspero, J. F.
    Castro, M.
    Zhu, H.
    Staudinger, H.
    Pirozzi, G.
    Antoni, C.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial
    Nakajima, Atsushi
    Seki, Mitsunori
    Taniguchi, Shinya
    Ohta, Akira
    Gillberg, Per-Goran
    Mattsson, Jan P.
    Camilleri, Michael
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (08): : 537 - 547
  • [43] EFFICACY AND SAFETY OF ABRILUMAB IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS OF A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, MULTIPLE-DOSE, PLACEBO-CONTROLLED STUDY
    Sandborn, William J.
    Cyrille, Marcoli
    Hansen, Mark Berner
    Feagan, Brian G.
    Loftus, Edward V.
    Rogler, Gerhard
    Vermeire, Severine
    Cruz, Martha L.
    Yang, Jun
    Sullivan, Barbara A.
    Reinisch, Walter
    GASTROENTEROLOGY, 2017, 152 (05) : S198 - S198
  • [44] Efficacy and safety of abrilumab in subjects with moderate to severe ulcerative colitis: results of a phase 2b, randomised, double-blind, multiple-dose, placebo-controlled study
    Sandborn, W. J.
    Cyrille, M.
    Hansen, M. B.
    Feagan, B. G.
    Loftus, E. V., Jr.
    Rogler, G.
    Vermeire, S.
    Cruz, M. L.
    Yang, J.
    Sullivan, B. A.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S21 - S22
  • [45] Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study
    Takeshima, Takao
    Sakai, Fumihiko
    Hirata, Koichi
    Imai, Noboru
    Matsumori, Yasuhiko
    Yoshida, Ryuji
    Peng, Cheng
    Cheng, Sunfa
    Mikol, Daniel D.
    HEADACHE, 2021, 61 (06): : 927 - 935
  • [46] Efficacy and Safety of Brodalumab In Patients With Moderate To Severe Plaque Psoriasis: Results of AMAGINE-1, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Papp, K.
    Reich, K.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Gottlieb, A. B.
    Thaci, D.
    Li, J.
    Nirula, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [47] Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-Blind, placebo-controlled study
    Papp, Kim
    Reich, Kristian
    Leonardi, Craig
    Paul, Carle
    Blauvelt, Andrew
    Baran, Wojciech
    Bolduc, Chantal
    Toth, Darryl
    Langley, Richard G.
    Cather, Jennifer
    Gottlieb, Alice
    Thaci, Diamant
    Milmont, Cassandra E.
    Lim, Joanne
    Klekotka, Paul
    Kricorian, Greg
    Nirula, Ajay
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [48] EFFICACY AND SAFETY OF RISANKIZUMAB: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO- AND USTEKINUMAB-CONTROLLED, PHASE 3 TRIALS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS
    Gordon, Kenneth B.
    Strober, Bruce
    Lebwohl, Mark
    Augustin, Matthias
    Blauvelt, Andrew
    Poulin, Yves
    Papp, Kim A.
    Sofen, Howard
    Puig, Lluis
    Foley, Peter
    Ohtsuki, Mamitaro
    Flack, Mary
    Geng, Ziqian
    Gu, Yihua
    Valdes, Joaquin M.
    Thompson, Elizabeth H. Z.
    Bachelez, Herve
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 28 - 29
  • [49] Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial
    Merola, Joseph F.
    Parish, Lawrence Charles
    Guenther, Lyn
    Lynde, Charles
    Lacour, Jean -Philippe
    Staubach, Petra
    Cheng, Sue
    Paris, Maria
    Picard, Hernan
    Deignan, Cynthia
    Jardon, Shauna
    Chen, Mindy
    Papp, Kim A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 485 - 493
  • [50] Commentary on "Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study"
    Hausauer, Amelia K.
    DERMATOLOGIC SURGERY, 2024, 50 (06) : 534 - 534
12345